Re: FDA approves Zulresso

Posted by Hugh on March 21, 2019, at 0:24:34

In reply to FDA approves Zulresso, posted by Hugh on March 19, 2019, at 21:44:19

SAGE-217, the oral version of Zulresso, is expected to be approved by the FDA this spring or summer. If this happens, any physician in the US will be allowed to prescribe SAGE-217 off-label for major depressive disorder, bipolar disorder, anxiety, PTSD, insomnia.

Thread

FDA approves Zulresso Hugh 3/19/19
Re: FDA approves Zulresso Hugh 3/21/19
Re: FDA approves Zulresso » Hugh SLS 3/21/19
Re: FDA approves Zulresso Lamdage22 3/21/19
Re: FDA approves Zulresso » Hugh beckett2 3/21/19
Re: FDA approves Zulresso » Lamdage22 Hugh 3/21/19
Re: FDA approves Zulresso » beckett2 Hugh 3/21/19
Re: FDA approves Zulresso » SLS Hugh 3/23/19
Re: FDA approves Zulresso Lamdage22 6/5/19
Re: FDA approves Zulresso Lamdage22 6/5/19

Post a new follow-up

Notify the administrators

Start a new thread

poster:Hugh thread:1103636
URL: http://www.dr-bob.org/babble/20190206/msgs/1103652.html